Increased AEA-mediated CB1R activation was also reported to contribute to other inflammatory and fibrotic disorders, such as skin fibrosis (35), kidney injury and fibrosis (36), liver cirrhosis (37), and diabetic cardiomyopathy (38). This evidence concerns the gene CNR1 and diabetic cardiomyopathy.